Home › Medical Devices › Drug Delivery Devices
Drug Delivery Devices Market Research Report
Drug delivery technologies can be classified on the basis of the four delivery routes: oral, transdermal, inhalation, and parenteral. These innovative technologies are highly useful in protein and gene-based therapies. Upcoming drug delivery technologies are focusing on boosting sales volume through improved safety and efficacy. The market has a large number of suppliers offering products with multiple applications; but it still offers plentiful opportunities to new entrants wishing to tap niche market segments.
Market Reports
| Title | Published | Price | TOC Available |
|---|---|---|---|
Drug - Device Combination (2009 - 2014)This report analyzes the basic structure of the drug-device combination market and its various submarkets. Individual markets for major products such as anti-microbial catheters, wound-care products, bone-graft substitutes, bone cement, drug-eluting stents, photodynamic therapy, artificial pancreas, and steroid eluting electrodes are further broken down into their respective sub-segments based on products, technology and applications. |
November 2009 | $ 4650 |
|
Top 10 Drug Delivery Technologies (2010 - 2015)This report provides industry analysis, competitive landscape and in-depth market segmentation for all the top 10 drug delivery technologies. It provides market data for the oral delivery system, which still dominates the drug delivery market. In addition, the report also analyzes the market data on emerging drug delivery technologies like needleless injectables, PEGylation technologies and microelectromechanical devices. |
October 2010 | $ 4650 |
|
Diabetes Market (Devices and Drugs)Sedentary lifestyle has led to the increase in diabetic patients and increasing awareness of side effects caused if left undiagnosed has increased the number of patients turning out for diagnosis and regular check. Additionally diabetes devices has also been a leading market in home healthcare segment as well, with introduction of handy glucose monitors. The market is evidencing continued innovation addressing issues pertaining to painless and user friendly diagnostic devices, drugs with less side effects, Insulin delivery systems etc. The market dynamics in this industry compels the competitors to be aware of the competitive moves to enhance market revenues and retain market share |
October 2010 | $ 4650 |